Alessio Mola, Technical Officer (Cancer Medicines) at World Health Organization, shared a post on LinkedIn:
“A child’s chance of surviving cancer should not depend on where they are born.
Closing the childhood cancer survival gap requires more than supplying medicines. It requires healthier, more sustainable markets that can reliably deliver the medicines children need.
Today, we are launching Closing the childhood cancer survival gap through sustainable access to medicines: Market Shaping Strategy 2026–2030.
Through 10 coordinated interventions, the strategy sets out a pathway towards sustainable access to affordable, quality-assured childhood cancer medicines, enabling more children to complete treatment and have the chance to survive and thrive.
You can also read: WHO Unveils 2026–2030 Strategy to Close the Childhood Cancer Medicines Gap
